H1N1 (swine) flu - Revision history

ClaireLewis: /* Management */

2017-02-26T00:11:25Z

Management

← Revisión anterior		Revisión del 00:11 26 feb 2017
Línea 23:		Línea 23:

	==Management==		==Management==
	*Adult: Tamiflu 75-mg capsule twice per day for 5 days		*Adult: [[Tamiflu]] 75-mg capsule twice per day for 5 days
	**All hospitalized patients with confirmed, probable or suspected novel influenza (H1N1)		**All hospitalized patients with confirmed, probable or suspected novel influenza (H1N1)
	**Patients who are at higher risk for seasonal influenza complications		**Patients who are at higher risk for seasonal influenza complications
Línea 30:		Línea 30:

	===Post-exposure chemoprophylaxis===		===Post-exposure chemoprophylaxis===
	*Tamiflu 75mg PO daily x 10 days (10 days after the last known exposure to novel (H1N1) influenza)		*[[Tamiflu]] 75mg PO daily x 10 days (10 days after the last known exposure to novel (H1N1) influenza)

	''If the contact occurred with a patient after 7 days of ~~symtpom~~ onset, then chemoprophylaxis is not necessary. This is the presumed post-infectious period.''		''If the contact occurred with a patient after 7 days of symptom onset, then chemoprophylaxis is not necessary. This is the presumed post-infectious period.''

	==Disposition==		==Disposition==

Rossdonaldson1: Text replacement - "DM" to "Diabetes mellitus"

2016-09-24T13:48:52Z

Text replacement - "*DM" to "*Diabetes mellitus"

← Revisión anterior		Revisión del 13:48 24 sep 2016
Línea 5:		Línea 5:
	*Immunosuppressed		*Immunosuppressed
	*Cardiac		*Cardiac
	*DM		*[[Diabetes mellitus]]

	===Screening===		===Screening===

Neil.m.young: Text replacement - "==Diagnosis==" to "==Evaluation=="

2016-07-24T11:45:53Z

Text replacement - "==Diagnosis==" to "==Evaluation=="

← Revisión anterior		Revisión del 11:45 24 jul 2016
Línea 17:		Línea 17:


	==~~Diagnosis~~==		==Evaluation==
	*Rapid Flu nasal swab 60-80% sensitive in detecting influenza A		*Rapid Flu nasal swab 60-80% sensitive in detecting influenza A
	**If patient is negative, severely ill and will be hospitalized, send viral culture		**If patient is negative, severely ill and will be hospitalized, send viral culture

Rossdonaldson1: Text replacement - "incr " to "increased "

2016-07-14T16:16:56Z

Text replacement - "incr " to "increased "

← Revisión anterior		Revisión del 16:16 14 jul 2016
Línea 1:		Línea 1:
	==Background==		==Background==
	===High-risk groups===		===High-risk groups===
	*Pregnant- ~~incr~~ rates of SAB, preterm labor		*Pregnant- increased rates of SAB, preterm labor
	*Chronic lung disease		*Chronic lung disease
	*Immunosuppressed		*Immunosuppressed

Mholtz: Mholtz moved page H1N1 (Swine) Flu to H1N1 (swine) flu

2015-08-22T09:57:08Z

Mholtz moved page H1N1 (Swine) Flu to H1N1 (swine) flu

← Revisión anterior	Revisión del 09:57 22 ago 2015
(Sin diferencias)

Mholtz at 09:56, 22 August 2015

2015-08-22T09:56:51Z

← Revisión anterior		Revisión del 09:56 22 ago 2015
Línea 1:		Línea 1:
	==High-risk groups==		==Background==
	#Pregnant- incr rates of SAB, preterm labor		===High-risk groups===
	#Chronic lung disease		*Pregnant- incr rates of SAB, preterm labor
	#Immunosuppressed		*Chronic lung disease
	#Cardiac		*Immunosuppressed
	#DM		*Cardiac
			*DM

			===Screening===
			*Individuals with an acute febrile respiratory illness (a measured temperature of 100ºF or higher and recent onset of at least one of the following: rhinorrhea, nasal congestion, sore throat, or cough) or sepsis-like syndrome.
			*HIGH PRIORITY for hospitalized patients and those at high-risk for severe disease.

			==Clinical Features==


			==Differential Diagnosis==

	~~==Screening==~~
	Individuals with an acute febrile respiratory illness (a measured temperature of 100ºF or higher and recent onset of at least one of the following: rhinorrhea, nasal congestion, sore throat, or cough) or sepsis-like syndrome- HIGH PRIORITY for hospitalized patients and those at high-risk for severe disease.

	==Diagnosis==		==Diagnosis==
	#Rapid Flu nasal swab 60-80% sensitive in detecting influenza A		*Rapid Flu nasal swab 60-80% sensitive in detecting influenza A
	#If patient is negative, severely ill and will be hospitalized, send viral culture		**If patient is negative, severely ill and will be hospitalized, send viral culture
	#PCR is the recommended confirmatory test		*PCR is the recommended confirmatory test

			==Management==
			*Adult: Tamiflu 75-mg capsule twice per day for 5 days
			**All hospitalized patients with confirmed, probable or suspected novel influenza (H1N1)
			**Patients who are at higher risk for seasonal influenza complications

	~~==Treatment==~~		''Most effective when started within 48 hours of illness onset.''
	~~#All hospitalized patients with confirmed, probable or suspected novel influenza (H1N1)~~
	~~#Patients who are at higher risk for seasonal influenza complications~~

	~~Most effective when started within 48 hours of illness onset.~~		===Post-exposure chemoprophylaxis===
			*Tamiflu 75mg PO daily x 10 days (10 days after the last known exposure to novel (H1N1) influenza)

	~~Adult: 75~~-~~mg capsule twice per day for 5 days~~		''If the contact occurred with a patient after 7 days of symtpom onset, then chemoprophylaxis is not necessary. This is the presumed post-infectious period.''

	===~~Post-exposure chemoprophylaxis~~===		==Disposition==
	~~#Tamiflu 75mg po daily x 10 days (10 days after the last known exposure to novel (H1N1) influenza.)~~

	~~If the contact occurred with a patient after 7 days of symtpom onset, then chemoprophylaxis is not necessary. This is the presumed post-infectious period.~~

	==See Also==		==See Also==
	*[[Influenza]]		*[[Influenza]]

			==References==
			<references/>

	[[Category:ID]]		[[Category:ID]]

Rossdonaldson1: /* Post-exposure chemoprophylaxis */

2014-10-03T06:45:11Z

Post-exposure chemoprophylaxis

← Revisión anterior		Revisión del 06:45 3 oct 2014
Línea 26:		Línea 26:

	If the contact occurred with a patient after 7 days of symtpom onset, then chemoprophylaxis is not necessary. This is the presumed post-infectious period.		If the contact occurred with a patient after 7 days of symtpom onset, then chemoprophylaxis is not necessary. This is the presumed post-infectious period.

			==See Also==
			*[[Influenza]]

	[[Category:ID]]		[[Category:ID]]

Rossdonaldson1 at 13:17, 12 March 2011

2011-03-12T13:17:52Z

@@ Línea 1: / Línea 1: @@
-CDC 2009
+==High-risk groups==
+#Pregnant- incr rates of SAB, preterm labor
--March/April 2009, an outbreak of H1N1 influenza A virus infection was first detected in Mexico.
+#Chronic lung disease
+#Immunosuppressed
--June 11, 2009, WHO raised its pandemic alert level to the highest level, phase 6, indicating widespread community transmission on at least two continents.
+#Cardiac
+#DM
 Individuals with an acute febrile respiratory illness (a measured temperature of 100ºF or higher and recent onset of at least one of the following: rhinorrhea, nasal congestion, sore throat, or cough) or sepsis-like syndrome- HIGH PRIORITY for hospitalized patients and those at high-risk for severe disease.
+==Diagnosis==
-Tests:
+==Treatment==
 Most effective when started within 48 hours of illness onset.
 Adult: 75-mg capsule twice per day for 5 days
+===Post-exposure chemoprophylaxis===
+#Tamiflu 75mg po daily x 10 days (10 days after the last known exposure to novel (H1N1) influenza.)
 If the contact occurred with a patient after 7 days of symtpom onset, then chemoprophylaxis is not necessary. This is the presumed post-infectious period.
 [[Category:ID]]

Robot: Created page with "CDC 2009 -March/April 2009, an outbreak of H1N1 influenza A virus infection was first detected in Mexico. -June 11, 2009, WHO raised its pandemic alert level to the highest lev..."

2010-10-29T22:44:11Z

Created page with "CDC 2009 -March/April 2009, an outbreak of H1N1 influenza A virus infection was first detected in Mexico. -June 11, 2009, WHO raised its pandemic alert level to the highest lev..."

Página nueva

CDC 2009

-March/April 2009, an outbreak of H1N1 influenza A virus infection was first detected in Mexico.

-June 11, 2009, WHO raised its pandemic alert level to the highest level, phase 6, indicating widespread community transmission on at least two continents.

Age distribution:

Oddly infection occurs disproportionately in individuals who are not at the extremes of age.

Distrubtion ages 5 and 24-years-old.

Few cases and no deaths reported in people older than 64 years old (? previous immunity)

High-risk groups:

Pregnant- incr rates of SAB, preterm labor

Chronic lung disease

Immunosuppressed

Cardiac

DM

Screening:

Individuals with an acute febrile respiratory illness (a measured temperature of 100ºF or higher and recent onset of at least one of the following: rhinorrhea, nasal congestion, sore throat, or cough) or sepsis-like syndrome- HIGH PRIORITY for hospitalized patients and those at high-risk for severe disease.

Tests:

Rapid Flu nasal swab 60-80% sensitive in detecting influenza A

If patient is negative, severely ill and will be hospitalized, send viral culture

PCR is the recommended confirmatory test

Treatment:

* All hospitalized patients with confirmed, probable or suspected novel influenza (H1N1).
* Patients who are at higher risk for seasonal influenza complications
Most effective when started within 48 hours of illness onset.

Adult: 75-mg capsule twice per day for 5 days

Post-exposure antiviral chemoprophylaxis is recommended for those with close contacts:

Tamiflu 75mg po daily x 10 days (10 days after the last known exposure to novel (H1N1) influenza.)

If the contact occurred with a patient after 7 days of symtpom onset, then chemoprophylaxis is not necessary. This is the presumed post-infectious period.

[[Category:ID]]